§ 13F · FUND PROFILE
Merck & Co., Inc..
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $215.6T (13F)Positions · 13Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
No new positions
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | PSNL | PERSONALIS INC | 14.04M | $111.8T | 40.5% | ±0% |
| 2 | MRNA | MODERNA INC | 2.31M | $68.1T | 24.6% | ±0% |
| 3 | KYMR | KYMERA THERAPEUTICS INC | 772K | $60.1T | 21.7% | ±0% |
| 4 | TRDA | ENTRADA THERAPEUTICS INC | 1.74M | $17.9T | 6.5% | ±0% |
| 5 | EVAXUSD | EVAXION BIOTECH A/S | 1.21M | $5.8T | 2.1% | ±0% |
| 6 | ALEC | ALECTOR INC | 3.55M | $5.5T | 2.0% | ±0% |
| 7 | STRO | SUTRO BIOPHARMA INC | 272K | $3.2T | 1.1% | −90% |
| 8 | VRDN | VIRIDIAN THERAPEUTICS INC | 93K | $2.9T | 1.1% | ±0% |
| 9 | XLO | XILIO THERAPEUTICS INC | 1.48M | $949.9B | 0.3% | ±0% |
| 10 | CARM | CARISMA THERAPEUTICS INC | 1.47M | $63.3B | 0.0% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE MERCK SIGNAL
AC read
Merck & Co., Inc. is a Other fund managing $215600.3 trillion in assets. The fund runs a focused portfolio of just 13 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q2 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed